CorMedix (CRMD) Misses Q2 EPS by 1c
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on CorMedix (CRMD) click here.
CorMedix (NASDAQ: CRMD) reported Q2 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on CorMedix (CRMD) click here.